Filter
1200
Text search:
viral
hepatitis
Featured
165
318
Language
Document type
621
275
112
61
56
27
23
10
5
4
1
1
1
Countries / Regions
58
39
35
25
24
23
21
21
21
21
21
20
19
17
16
16
15
15
13
12
12
11
11
11
10
10
9
9
8
8
7
7
7
6
5
5
5
5
4
4
4
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
462
153
42
41
39
22
19
1
Toolboxes
298
97
58
36
31
29
28
26
24
21
20
15
11
11
9
9
8
7
7
6
5
1
1
The WHO guidelines provide recommended steps for safe phlebotomy and reiterate accepted principles for drawing, collecting blood and transporting blood to laboratories/blood banks.
Strengthening HIV prevention among most-at-risk populations (MARPs) in the Syrian Arab Republic:
Updated 6 September 2016. This guidance has been developed to provide advice on the prevention of potential sexual transmission of Zika virus. The primary transmission route of Zika virus is via the Aedes mosquito. However, sexual transmission of Zika virus may also be possible, with limited evidenc
...
Infection Control Assessment Tool
recommended
Strengthening Parmaceutical Systems. 2nd edition
EACS produces Guidelines for the management of people living with HIV in Europe. The English version is regularly updated by the guidelines panels with major revision every other year and minor revisions in the years in between. Guidelines are published in the autumn and translated into additional l
...
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
Public Health Situation Analysis and Interventions 10 October 2017
Updated to Reflect the 2009 Medical Eligibility Criteria of the World Health Organization
This manual provides practical guidelines for the management of children with severe malnutrition. It seeks to promote the best available therapy so as to reduce the risk of death, shorten the length of time spent in hospital, and facilitate rehabilitation and full recovery. Emphasis is given to the
...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
